Annexin (ANNX.ST) traded down -2.33 % during a 24 hours period ending at 08:13 AM Central Europe on Tuesday 27th. One Annexin stock can currently be bought for about SEK 7.56 on popular exchanges. Current supply of Annexin stocks is 8.7 mn. Annexin has a current market capitalization of SEK 64.7 mn and approximately SEK 58.2 k worth of Annexin was traded on exchanges in the last 24 hours. Since last month end, Annexin has traded -14.86 % down. Simple moving average of last 200 days is at SEK 13.33. The highest price of past 52 weeks was recorded at SEK 28 on 10/30/2025. 52 weeks low was at SEK 7.42 on 10/26/2026.
Here is how related stocks have performed in the past 24 hours:
Kentima (KENH.ST) traded down -9.22 % and now trades at SEK 2.56. Current market capitalisation for Kentima is SEK 74.7 mn. Kentima has a current price to earnings ratio of 18.51.
Prostatype Genomics (PROGEN.ST) traded flat 0 % and now trades at SEK 0.1. Prostatype Genomics has a market capitalisation of SEK 70.5 mn.
Xoma (QM8.F) traded down -6.75 % and now trades at EUR 0.06. Xoma has a market capitalisation of EUR 6.4 mn.
Enorama Pharma (ERMA.ST) traded up 28.87 % and now trades at SEK 1. Current market capitalisation for Enorama Pharma is SEK 75.3 mn.
Idl Diagnostics (AROC.ST) traded down -4 % and now trades at SEK 0.32. Idl Diagnostics has a market capitalisation of SEK 73.7 mn.
About Annexin
Annexin Pharmaceuticals AB is a biotechnology company operating in the health care sector, specializing in pharmaceuticals. The company offers a human recombinant protein for emergency treatment of patients with cardiovascular diseases characterized by damage and inflammation in the blood vessels. Annexin Pharmaceuticals serves customers in Sweden. The company’s website is www.annexinpharma.com , and it is listed on the Swedish Stock Exchange.